Company attributes
Location
B2X
CEO
Pitchbook URL
Legal Name
Metacrine, Inc.
Date Incorporated
January 1, 2014
Number of Employees (Ranges)
11 – 50
Email Address
investors@metacrine.com0
Phone Number
+185836978000
Number of Employees
17
Full Address
4225 Executive Square, Suite 600 San Diego, CA 92037, USA0
CIK Number
Place of Incorporation
Investors
IRS Number
472,297,3840
Founded Date
2014
0Fax Number
(858) 369-78250
Total Funding Amount (USD)
65,000,000
Latest Funding Round Date
June 6, 2018
Competitors
Stock Symbol
MTCR0
Exchange
Board of Directors
Latest Funding Type
Patents Assigned (Count)
8
Country
Other attributes
Company Operating Status
Active
Contact Page URL
Latest Funding Round Amount (USD)
65,000,000
Market Capitalization
20,880,000
SIC Code
2,8340
Ticker Symbol
MTCR
Metacrine is a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal (GI) and liver diseases. Its most advanced program targets the farnesoid X receptor (FXR), which is central to modulating GI and liver diseases. Company believes that potency, sustained exposure and continuous target engagement are key to optimizing therapeutic benefit with an FXR targeted therapy. Leveraging our extensive chemistry and biology expertise, it has built a proprietary library of over 2,500 FXR compounds and have selected MET642 to advance into a Phase 2 study in ulcerative colitis.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
